SCHEMBL5458477

SCHEMBL5458477

Cc1cccc(NC(=O)Nc2ccc(N3CCN(C(=O)OC(C)(C)C)CC3)cc2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 1/20 0.61
GPR119 Q8TDV5 2/20 0.58
MAPT P10636 4/20 0.58
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
TSHR P16473 1/20 0.58
NPC1 O15118 3/20 0.53
PKM P14618 2/20 0.53
ALDH1A1 P00352 3/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2C9 P11712 1/20 0.52
LMNA P02545 2/20 0.51
GAA P10253 1/20 0.51
RAB9A P51151 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
CYP2C19 P33261 1/20 0.51
PDGFRB P09619 1/20 0.51
KDR P35968 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5454509 0.88 NAMPT (0.60) NAMPTMAPTMEN1KMT2ASMN1; SMN2
SCHEMBL5466103 0.87 NAMPT (0.59) NAMPTMAPTMEN1KMT2ASMN1; SMN2
SCHEMBL5466962 0.86 NAMPT (0.58) NAMPTMAPTMEN1KMT2ASMN1; SMN2
SCHEMBL5466989 0.85 NAMPT (0.59) NAMPTGPR119MAPTMEN1KMT2A
SCHEMBL5459909 0.85 NAMPT (0.56) NAMPTGPR119MAPTMEN1KMT2A
SCHEMBL5456796 0.85 NAMPT (0.56) NAMPTMAPTMEN1KMT2ASMN1; SMN2
SCHEMBL5465333 0.83 MAPT (0.56) NAMPTGPR119MAPTMEN1KMT2A
SCHEMBL5465659 0.83 NAMPT (0.54) NAMPTGPR119MAPTMEN1KMT2A
SCHEMBL5460938 0.83 NAMPT (0.64) NAMPTGPR119MAPTMEN1KMT2A
SCHEMBL13853617 0.83 NAMPT (0.66) NAMPTGPR119MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed
EP-1764360-A1 UREA DERIVATIVE Sankyo Company, Limited (JP) 2007-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 NAMPT 324/4885GPR119 162/4885MAPT 758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.